Common reasons for hospitalization among adult patients with diabetes

Endocrine Practice

Volumn 12, Issue 4, 2006, Pages 363-370

  Cook, Curtiss B ^a   Tsui, Circe ^b   Ziemer, David C ^b   Naylor, Dorothy B ^c   Miller, William J ^d  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Georgia Regional Hospital   (United States)

^d School of Health Sciences Clayton College and State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELLULITIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOVOLEMIA; INJURY; INTOXICATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEOPLASM; NEUROLOGIC DISEASE; OUTPATIENT CARE; PNEUMONIA; PROSTHESIS INFECTION; RESPIRATORY FAILURE; SEPTICEMIA; URINARY TRACT INFECTION; ADOLESCENT; CROSS-SECTIONAL STUDY; INFECTION; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; INFECTION; MALE; MIDDLE AGED; PATIENT DISCHARGE; PNEUMONIA;

EID: 33750124785     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.12.4.363     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention. The public health burden of diabetes mellitus in the United States. In: Diabetes Surveillance, 1997. Atlanta, GA: U.S. Department of Health and Human Services, 1997: 1-15.
2. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23: 1278-1283.
3. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
5. Aubert RE, Geiss LS, Ballard DJ, Cocanougher B, Herman WH. Diabetes-related hospitalization and hospital utilization. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 553-569. Available at: http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/ chapter27.pdf. Accessed for verification January 22, 2006.
6. Elixhauser A, Yu K, Steiner C, Bierman AS. Hospitalization in the United States, 1997. Rockville, MD: Agency for Healthcare Research and Quality; May 2000. HCUP Fact Book No. 1; AHRQ Publication No. 00-0031. Available at: http://www.ahrq.gov/data/hcup/factbk1/hcupfbk1.pdf Accessed for verification January 22, 2006.
7. Centers for Disease Control and Prevention. Data & Trends: National Diabetes Surveillance System; Hospitalizations for Diabetes as First-Listed Diagnosis. Atlanta, GA; January 18, 2005. Available at: http://www.cdc.gov/diabetes/statistics/dmfirst/table1.htm. Accessed for verification January 22, 2006.
8. Centers for Disease Control and Prevention. Data & Trends: National Diabetes Surveillance System; Hospitalizations for Diabetes as Any-Listed Diagnosis. Atlanta, GA; January 18, 2005. Available at: http://www.cdc.gov/diabetes/statistics/dmany/fig1.htm. Accessed for verification January 22, 2006.
9. Jiang HJ, Stryer D, Friedman B, Andrews R. Multiple hospitalizations for patients with diabetes. Diabetes Care. 2003;26:1421-1426.
10. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20:1396-1402.
11. Hogan P, Dall T, Nikolov P (American Diabetes Association). Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
12. Ray NF, Thamer M, Taylor T, Fehrenbach SN, Ratner R. Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab. 1996;81:3671-3679.
13. Centers for Disease Control and Prevention. Data & Trends: National Diabetes Surveillance System; Causes of Hospitalizations. Atlanta, GA; January 18, 2005. Available at: http://www.cdc.gov/diabetes/statistics/ hosp/adult-table1.htm. Accessed for verification January 22, 2006.
14. International Classification of Diseases, 9th Revision, Clinical Modification: Med-Index ICD-9-CM. 4th ed. Salt Lake City, UT: Med-Index Publications, 1993.
15. Elixhauser A, Steiner CA, Whittington CA, McCarthy E. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995, Rockville, MD: Agency for Health Care Policy and Research. HCUP No. 3; AHCPR Publication No. 98-0049. Available at: http://www.hcup-us.ahrq.gov/reports/natstats/his95/clinclas.htm. Accessed for verification January 22, 2006.
16. Elixhauser A, McCarthy E. Clinical Classifications for Health Policy Research, Version 2: Hospital Inpatient Statistics. Rockville, MD: Agency for Health Care Policy and Research, 1996. HCUP No. 3; AHCPR Publication No. 96-0017.
17. Elixhauser A, Steiner C, Palmer L. Clinical Classifications Software (CCS), 2006. U.S. Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/CCSUsersGuide. Accessed for verification January 22, 2006.
18. Boyko EJ, Lipsky BA. Infection and diabetes. In: Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 485-499. Available at: http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/chapter22.pdf. Accessed for verification January 22, 2006.
19. Weissman JS, Gatsonis C, Epstein AM. Rates of avoidable hospitalization by insurance status in Massachusetts and Maryland. JAMA. 1992;268:2388-2394.
20. Pappas G, Hadden WC, Kozak LJ, Fisher GF. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health. 1997;87:811-816.
21. Davis SK, Liu Y, Gibbons GH. Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks [erratum in Am J Public Health. 2003;93:703]. Am J Public Health. 2003;93:447-455.
22. Booth GL, Hux JE. Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med. 2003;163:101-106.
23. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 429-448. Available at: http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/ chapterl9.pdf. Accessed for verification January 22, 2006.
24. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study [erratum in JAMA. 1989;261:1884]. JAMA. 1988;260:3456-3460.
25. Herlitz J, Karlson BW, Edvardsson N, Emanuelsson H, Hjalmarson A. Prognosis in diabetics with chest pain or other symptoms suggestive of acute myocardial infarction. Cardiology. 1992;80:237-245.
26. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717-1723.
27. Miettinen H, Lehto S, Salomaa V, et al (FINMONICA Myocardial Infarction Register Study Group). Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21:69-75.
28. Geiss LS, Herman WH, Smith PJ. Mortality in noninsulin-dependent diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 233-257. Available at: http:// diabetes.niddk.nih.gov/dm/pubs/america/pdf/chapter11.pdf. Accessed for verification January 22, 2006.
29. Portuese E, Orchard T. Mortality in insulin-dependent diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995: 221-232. Available at: http://diabetes.niddk.nih.gov/dm/ pubs/america/pdf/chapter10.pdf. Accessed for verification January 22, 2006.
30. Cook CB, Miller WJ, Ziemer DC, et al. Diabetes increases risk of cardiovascular disease-related hospitalizations [abstract]. Prev Med. 2004;39:S17.
31. Hockensmith ML, Estacio RO, Mettler P, et al. Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. J Card Fail. 2004; 10: 126-131.
32. Ofili EO, Mayberry R, Alema-Mensah E, et al. Gender differences and practice implications of risk factors for frequent hospitalization for heart failure in an urban center serving predominantly African-American patients. Am J Cardiol. 1999;83:1350-1355.
33. Hurst RT, Lee RW. Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management. Ann Intern Med. 2003;139:824-834.
34. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
35. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet. 2002;360:7-22.
36. Harpaz D, Gottlieb S, Graff E, Boyko V, Kishon Y, Behar S (Israeli Bezafibrate Infarction Prevention Study Group). Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Am J Med. 1998; 105:494-499.
37. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study report 14. JAMA. 1992;268:1292-1300.
38. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy [erratum in Lancet. 2000;356:860]. Lancet. 2000;355:253-259.
39. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
40. Grant RW, Buse JB, Meigs JB (University Health System Consortium [UHC] Diabetes Benchmarking Project Team). Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-342.
41. Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med. 2004;21:150-155.
42. Musey VC, Lee JK, Crawford R, Klatka MA, McAdams D, Phillips LS. Diabetes in urban African-Americans: I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995;18:483-489.
43. Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal. vaccination coverage among persons aged ≥65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003 [erratum in MMWR Morb Mortal Wkly Rep. 2005;54:935]. MMWR Morb Mortal Wkly Rep. 2004;53:1007-1012.
44. Carral F, Olveira G, Aguilar M, et al. Hospital discharge records under-report the prevalence of diabetes in inpatients. Diabetes Res Clin Pract. 2003;59:145-151.
45. Masson EA, MacFarlane IA, Power E, Wallymahmed M. An audit of the management and outcome of hospital inpatients with diabetes: resource planning implications for the diabetes care team. Diabet Med. 1992;9:753-755.